Telesis Bio Releases BioXp® Select Kits to Enable DNA Amplification and Scale-up
March 31, 2023 09:00 ET
|
Telesis Bio
SAN DIEGO, March 31, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced continued expansion of the BioXp®...
Telesis Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Guidance
March 21, 2023 16:05 ET
|
Telesis Bio
-- Record revenue of $9.5M in 4QFY22; Increase of 208% over 4QFY21 -- BioXp® Revenue increased by 158% to $3.4M, in 4QFY22 over 4QFY21 SAN DIEGO, March 21, 2023 (GLOBE NEWSWIRE) -- Telesis Bio...
Telesis Bio to Present at Festival of Biologics Conference
March 16, 2023 06:00 ET
|
Telesis Bio
SAN DIEGO, March 16, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced Daniel Gibson, Ph.D., CTO and...
Telesis Bio präsentiert auf dem RNA Leaders Europe Kongress
March 14, 2023 15:16 ET
|
Telesis Bio
SAN DIEGO, March 14, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), ein führender Anbieter von automatisierten Lösungen für Multi-Omics und synthetische Biologie, gab heute bekannt, dass...
Telesis Bio s'apprête à réaliser des présentations lors du RNA Leaders Europe Congress
March 14, 2023 15:16 ET
|
Telesis Bio
SAN DIEGO, 14 mars 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ : TBIO), leader des solutions de biologie synthétique et de multiomique automatisées, a annoncé aujourd'hui que la société...
Telesis Bio to Present at RNA Leaders Europe Congress
March 14, 2023 06:00 ET
|
Telesis Bio
SAN DIEGO, March 14, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced they will be showcasing their...
Telesis Bio to Report Fourth Quarter and Full Year 2022 Financial Results on Tuesday, March 21, 2023
March 09, 2023 16:30 ET
|
Telesis Bio
SAN DIEGO, March 09, 2023 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced that it will release its fourth quarter...
Telesis Bio to Present at the Cowen 43rd Annual Healthcare Conference
February 27, 2023 09:00 ET
|
Telesis Bio
SAN DIEGO, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced that Todd R. Nelson, PhD, the...
Telesis Bio Releases BioXp® Select mRNA Synthesis Kit to Expand the Utility, Speed, and Impact of Its Automated Synthetic Biology Workstation
February 16, 2023 09:00 ET
|
Telesis Bio
SAN DIEGO, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the availability of its BioXp® Select...
Telesis Bio Pre-Announces Preliminary Fourth Quarter Financial Results
January 09, 2023 09:00 ET
|
Telesis Bio
-- Record revenue of $9M in 4QFY22; Increase of 191% over 4QFY21 -- BioXp® Revenue increased by 131% to $3M, in 4QFY22 over 4QFY21 -- Successful achievement of first technical milestone with Pfizer...